CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 19 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $34,000 | +240.0% | 50,232 | +90.3% | 0.00% | +200.0% |
| Q3 2019 | $10,000 | -79.2% | 26,402 | -70.4% | 0.00% | -66.7% |
| Q2 2019 | $48,000 | +118.2% | 89,205 | +284.9% | 0.00% | +200.0% |
| Q1 2019 | $22,000 | 0.0% | 23,178 | -36.8% | 0.00% | 0.0% |
| Q4 2018 | $22,000 | +22.2% | 36,669 | +182.2% | 0.00% | 0.0% |
| Q3 2018 | $18,000 | -56.1% | 12,993 | -55.2% | 0.00% | -50.0% |
| Q2 2018 | $41,000 | -22.6% | 29,033 | -26.7% | 0.00% | -33.3% |
| Q1 2018 | $53,000 | -84.7% | 39,613 | -80.1% | 0.00% | -83.3% |
| Q4 2017 | $347,000 | +61.4% | 199,464 | +69.5% | 0.02% | +63.6% |
| Q3 2017 | $215,000 | – | 117,644 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 50,232 | $34,000 | 0.00% |
| Renaissance Technologies | 1,269,326 | $850,000 | 0.00% |
| VANGUARD GROUP INC | 106,172 | $71,000 | 0.00% |
| UBS Group AG | 7,627 | $5,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 9 | $0 | 0.00% |
| NORTHERN TRUST CORP | 13,399 | $9,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 162,686 | $108,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,286 | $0 | 0.00% |
| BlackRock Inc. | 796 | $1,000 | 0.00% |